{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:58:53Z","timestamp":1792594733149,"version":"4.5.0"},"reference-count":22,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Antibodies to platelet factor 4 (PF4) have been primarily linked to classical heparin-induced thrombocytopenia (cHIT). However, during the rollout of the COVID-19 vaccine program a new condition, vaccine-induced thrombocytopenia and thrombosis (VITT), was identified, related to adenoviral-based COVID-19 vaccines. The differences between these 2 conditions, both clinically and in laboratory testing, set the scene for the development of a new rapid anti-PF4 assay that is not linked with heparin (as relevant for cHIT). Concurrently, there has been a reassessment of those cases described as autoimmune HIT. Such scenarios do not follow cHIT, but there is now a clearer differentiation of heparin-dependent and heparin-independent anti-PF4 conditions. The importance of this distinction is the identification of heparin-independent anti-PF4 antibodies in a new subgroup termed VITT-like disorder. Cases appear to be rare, precipitated by infection and in a proportion of cases, orthopaedic surgery, but are associated with high mortality and the need for a different treatment pathway, which includes immunomodulation therapy.<\/jats:p>","DOI":"10.1182\/hematology.2024000565","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T15:04:12Z","timestamp":1733497452000},"page":"403-408","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["Demystifying autoimmune HIT: what it is, when to test, and how to treat"],"prefix":"10.1182","volume":"2024","author":[{"given":"Marie","family":"Scully","sequence":"first","affiliation":[{"name":"1 Department of Haematology, University College London Hospital, Haematology Theme-NIHR UCLH\/UCL BRC, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Lester","sequence":"additional","affiliation":[{"name":"2 Haemophilia Comprehensive Care Centre, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,12,6]]},"reference":[{"issue":"suppl 1","key":"2024121115504811000_hem2024000565C1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1538-7836.2011.04322.x","article-title":"HIT paradigms and paradoxes","volume":"9","author":"Warkentin","year":"2011","journal-title":"J Thromb Haemost"},{"key":"2024121115504811000_hem2024000565C2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.thromres.2021.05.018","article-title":"Spontaneous HIT syndrome: knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia","volume":"204","author":"Warkentin","year":"2021","journal-title":"Thromb Res"},{"key":"2024121115504811000_hem2024000565C3","doi-asserted-by":"crossref","first-page":"102681","DOI":"10.1016\/j.jaut.2021.102681","article-title":"Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines","volume":"122","author":"Hwang","year":"2021","journal-title":"J Autoimmun"},{"issue":"23","key":"2024121115504811000_hem2024000565C4","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N Engl J Med"},{"issue":"22","key":"2024121115504811000_hem2024000565C5","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"issue":"22","key":"2024121115504811000_hem2024000565C6","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"issue":"24","key":"2024121115504811000_hem2024000565C7","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1001\/jama.2021.7517","article-title":"US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination, March 2 to April 21, 2021","volume":"325","author":"See","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"2024121115504811000_hem2024000565C8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/hematology.2023000503","article-title":"Thrombotic anti-PF4 immune disorders: HIT, VITT, and beyond","volume":"2023","author":"Greinacher","year":"2023","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2024121115504811000_hem2024000565C9","article-title":"VITT-like syndrome associated with acute cytomegalovirus infection. How many cases are we missing?","volume-title":"Br J Haematol","author":"Nicolson"},{"issue":"7","key":"2024121115504811000_hem2024000565C10","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ajh.24025","article-title":"Pitfalls in the diagnosis of heparin-induced thrombocytopenia: a 6-year experience from a reference laboratory","volume":"90","author":"Nazi","year":"2015","journal-title":"Am J Hematol"},{"issue":"14","key":"2024121115504811000_hem2024000565C11","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1182\/blood-2017-06-788679","article-title":"Autoimmune HIT due to apheresis catheter heparin flushes for stem cell harvesting before autotransplantation for myeloma","volume":"130","author":"Mian","year":"2017","journal-title":"Blood"},{"issue":"5","key":"2024121115504811000_hem2024000565C12","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1111\/bjh.17917","article-title":"Therapeutic plasma exchange in severe refractory autoimmune heparin-induced thrombocytopenia with thrombosis","volume":"196","author":"Bavli","year":"2022","journal-title":"Br J Haematol"},{"issue":"21","key":"2024121115504811000_hem2024000565C13","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12216921","article-title":"Autoimmune heparin-induced thrombocytopenia","volume":"12","author":"Warkentin","year":"2023","journal-title":"J Clin Med"},{"issue":"5","key":"2024121115504811000_hem2024000565C14","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3324\/haematol.2021.280366","article-title":"Platelet-activating anti-PF4 antibodies mimic VITT antibodies in an unvaccinated patient with monoclonal gammopathy","volume":"107","author":"Greinacher","year":"2022","journal-title":"Haematologica"},{"issue":"4","key":"2024121115504811000_hem2024000565C15","doi-asserted-by":"crossref","first-page":"e12750","DOI":"10.1002\/rth2.12750","article-title":"Thrombotic thrombocytopenia after sinopharm BBIBP-CorV COVID-19 vaccination","volume":"6","author":"Hosseinzadeh","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"issue":"12","key":"2024121115504811000_hem2024000565C16","article-title":"Severe thrombocytopenia, thrombosis and anti-PF4 antibody after Pfizer-BioNTech COVID-19 mRNA vaccine booster\u2014is it vaccine-induced immune thrombotic thrombocytopenia?","volume":"10","author":"Ling","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"10","key":"2024121115504811000_hem2024000565C17","doi-asserted-by":"crossref","first-page":"E363","DOI":"10.1002\/ajh.26659","article-title":"Human papilloma virus vaccine and VITT antibody induction","volume":"97","author":"Kanack","year":"2022","journal-title":"Am J Hematol"},{"issue":"26","key":"2024121115504811000_hem2024000565C18","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1182\/blood.2023022136","article-title":"Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposure","volume":"142","author":"Sch\u00f6nborn","year":"2023","journal-title":"Blood"},{"issue":"26","key":"2024121115504811000_hem2024000565C19","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1182\/blood.2023022900","article-title":"VITT-like disorder HITs the headlines","volume":"142","author":"Scully","year":"2023","journal-title":"Blood"},{"issue":"6","key":"2024121115504811000_hem2024000565C20","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJMc2307721","article-title":"Adenovirus-associated thrombocytopenia, thrombosis, and VITT-like antibodies","volume":"389","author":"Warkentin","year":"2023","journal-title":"N Engl J Med"},{"issue":"18","key":"2024121115504811000_hem2024000565C21","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical features of vaccine-induced immune thrombocytopenia and thrombosis","volume":"385","author":"Pavord","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"2024121115504811000_hem2024000565C22","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1182\/blood-2017-08-803031","article-title":"Normal plasma IgG inhibits HIT antibody-mediated platelet activation: implications for therapeutic plasma exchange","volume":"131","author":"Jones","year":"2018","journal-title":"Blood"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2024\/1\/403\/2346510\/403scully.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2024\/1\/403\/2346510\/403scully.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T20:21:20Z","timestamp":1733948480000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2024\/1\/403\/526231\/Demystifying-autoimmune-HIT-what-it-is-when-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,6]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12,6]]},"published-print":{"date-parts":[[2024,12,6]]}},"URL":"https:\/\/doi.org\/10.1182\/hematology.2024000565","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12,6]]},"published":{"date-parts":[[2024,12,6]]}}}